Parallel Advisors’s Immunomedics Inc IMMU Stock Holding History

Parallel Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25	Closed	-$2K	–	2821
2020 Q3	$2K	Buy	+25	New	+$1.26K	﹤0.01%	2388
2017 Q4	–	Sell	-1,000	Closed	-$10K	–	2180
2017 Q3	$10K	Sell	1,000 -2,000	-67%	-$19.9K	﹤0.01%	1310
2017 Q2	$26K	Buy	+3,000	New	+$21.1K	﹤0.01%	912

Parallel Advisors's IMMU Position: Q4 2020 in Review

Parallel Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 25 shares — an estimated $2K sold.

Parallel Advisors first reported a position in IMMU in Q2 2017 and held it in 3 quarters. The position peaked at $26K in Q2 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Parallel Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Parallel Advisors sold 25 Immunomedics Inc shares in Q4 2020, an estimated $2K.
Parallel Advisors first reported a position in Immunomedics Inc in Q2 2017 and held it in 3 quarters.
Parallel Advisors's Immunomedics Inc position peaked at $26K in Q2 2017.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.